Charles River Labs Intl buy Barclays PLC
Start price
08.05.26
/
50%
€151.30
Target price
08.05.27
-
Performance (%)
33.97%
Price
05.08.26
€225.70
Summary
This prediction is currently active. With a performance of 33.97% the BUY prediction by Barclays_PLC is a big success. This prediction currently runs until 08.05.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Charles River Labs Intl | 9.990% | 9.990% |
| iShares Core DAX® | 3.153% | 1.504% |
| iShares Nasdaq 100 | 7.431% | -1.584% |
| iShares Nikkei 225® | 8.571% | -4.324% |
| iShares S&P 500 | 4.578% | 1.920% |
Comments by Barclays_PLC for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International (CRL) had its "overweight" rating reaffirmed by Barclays PLC.
Ratings data for CRL provided by MarketBeat
Stopped prediction by Barclays_PLC for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€149.35
06.11.25
06.11.25
€182.47
06.11.26
06.11.26
51.12%
05.08.26
05.08.26
Charles River Labs Intl
Start price
Target price
Perf. (%)
€149.30
02.10.25
02.10.25
€166.12
02.10.26
02.10.26
51.17%
05.08.26
05.08.26